Temperature Controlled Packaging for Pharmaceutical Market to Generate High Revenue

Pune, India, September 2019, MRFR Press Release/- Market Research Future has Published a Cooked Research Report on the Global Temperature Controlled Packaging for Pharmaceutical Market.

Market Scope

Market Research Future (MRFR), asserts that the Global Temperature-Controlled Packaging for Pharmaceutical Market is expected to exhibit a CAGR of 9.20% over the forecast period of 2022-2030 and value at USD 20.42 billionby 2030. Primarily, the increase in number of thermal-sensitive drugs is gaining traction for the market. The fast-paced expansion of the market is due to the growing need for preserving drugs and their raw materials form extreme temperature conditions.

Industry News

September 2019

Peli BioThermal, a leader in providing thermal-controlled packaging solutions, exhibited its solution at Defence and Security Equipment International (DSEI) 2019 for the first time.

Segmental Overview

The temperature-controlled packaging for pharmaceutical market is segmented by payload capacity, product, type of use, temperature range, type, and end-use industry. By product, the market is divided into insulated containers and insulated shippers. The insulated shippers segment is likely to lead in forecast period.

By type, the market is segmented into passive systems and active systems. The active systems segment is expected to expand at a CAGR of 9.14% over the review period.

By temperature range, the market is segmented into Up to 10°C, 10°C to 20°C, and more than 20°C. The up to 10°C segment is anticipated to thrive at 9.93% CAGR and touch USD 4,329.4 Million by 2023.

By payload capacity, the market is segmented into Up to 10 L, 10-20 L, 20-40 L, 40-150 L, and more than 150 L. The up to 10 L segment is likely to lead by a CAGR of 9.53% through the review period. The 40-150 L segment is expected to expand at a CAGR of 9.88% by 2023.

By type of use, the market is segmented into reusable and single-use. The single-use segment to direct the market growth.  

By end-use, the market is segmented into clinical trial and pharmaceutical. The pharmaceutical segment is projected to thrive at 10.08% CAGR over the assessment period.

Regional Outlook

Regionally, the temperature-controlled packaging for pharmaceutical market has been studied across Europe, Asia Pacific, North America, and the Rest of the World (RoW).

The ever-increasing pharmaceutical industry in North America is expected to impel the market growth in this region. Presence of pharmaceutical regulatory bodies in the region can cast a positive influence on the market. The US market is anticipated to show a healthy growth.

The Europe market is likely to expand by 9.42% over the review period. The existence of robust supply chain logistics is a major factor that is likely to determine the growth of the regional market. Other factors such as development of novel drugs and increase number of contract research organization (CROs) can surge the regional market. Germany to exhibit the highest growth rate.

The Asia Pacific market is likely to note a significant growth by registering a CAGR of 10.02%, in which China is expected to hold the maximum share of the regional market. The extensive number of pharmaceutical research and development activities taking place in China, include handling of temperature sensitive materials. The expansion in patient base owing to the change in lifestyle is leading to demand for developing effective medication. This, in turn, is gaining hefty investment from the government and wealthy private companies to conduct such research. This is noted to spur the growth of the APAC market over the coming years as innovations roll-out.

Key Players

Storopack Hans Reichenecker GmbH, va-Q-tec AG, Sofrigam, DB Schenker, Sonoco ThermoSafe, Cold Chain Technologies, United Parcel Service of America, Inc. (UPS), KUEHNE + NAGEL INC, Softbox Systems Limited, Envirotainer AB, Pelican Bio Thermal, and DHL International GmbH.

Access Report Details @ Temperature-Controlled Packaging for Pharmaceutical Market Size